Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-02-26 13:06 Tx date 2024-02-23 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+160,000 vol |
730,000 | |
Filed 2024-01-16 10:49 Tx date 2024-01-15 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc. (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$23,000
+100,000 vol $0.23 each |
1,666,704 | |
Filed 2024-01-16 10:47 Tx date 2024-01-15 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-100,000 vol |
570,000 | |
Filed 2023-06-20 13:47 Tx date 2023-06-20 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$241,200
+40,000 vol $6.03 each |
115,000 | |
Filed 2023-02-28 08:53 Tx date 2023-02-27 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+160,000 vol |
670,000 | |
Filed 2022-02-24 21:37 Tx date 2022-02-22 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+160,000 vol |
510,000 | |
Filed 2022-01-13 17:11 Tx date 2022-01-13 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$423,500
+50,000 vol $8.47 each |
75,000 | |
Filed 2022-01-13 16:59 Tx date 2022-01-13 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$423,500
+50,000 vol $8.47 each |
75,000 | |
Filed 2022-01-13 16:59 Tx date 2022-01-13 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$423,500
+50,000 vol $8.47 each |
||
Filed 2021-06-22 17:04 Tx date 2019-10-10 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$99,999
+1,428,571 vol $0.07 each |
2,857,142 | |
Filed 2021-06-22 17:02 Tx date 2020-01-03 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-1,423,809 vol |
1,433,333 | |
Filed 2021-06-22 17:02 Tx date 2019-10-10 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$99,999
+1,428,571 vol $0.07 each |
||
Filed 2021-06-22 16:59 Tx date 2019-09-09 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$99,999
+1,428,571 vol $0.07 each |
1,428,571 | |
Filed 2021-06-22 16:48 Tx date 2020-01-03 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-1,423,809 vol |
1,433,333 | |
Filed 2021-06-22 16:47 Tx date 2019-10-10 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$99,999
+1,428,571 vol $0.07 each |
2,857,142 | |
Filed 2021-06-22 16:47 Tx date 2019-10-10 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$99,999
+1,428,571 vol $0.07 each |
||
Filed 2021-06-22 16:45 Tx date 2019-03-15 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-01-03 15:55 Tx date 2020-01-03 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-1,423,809 vol |
||
Filed 2019-09-11 11:42 Tx date 2019-09-09 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$99,999
+1,428,571 vol $0.07 each |
||
Filed 2021-05-19 16:55 Tx date 2021-05-19 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc. (Control or Direction)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+83,333 vol |
83,333 | |
Filed 2021-05-19 16:54 Tx date 2021-05-19 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc. (Control or Direction)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$100,000
+166,667 vol $0.60 each |
1,566,704 | |
Filed 2021-03-30 13:58 Tx date 2021-03-29 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$106,000
+25,000 vol $4.24 each |
25,000 | |
Filed 2021-03-30 13:57 Tx date 2019-03-15 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-03-02 14:48 Tx date 2007-02-06 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
150,000 | |
Filed 2007-03-05 16:37 Tx date 2007-02-06 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
||
Filed 2021-02-26 18:13 Tx date 2020-10-16 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-216,000
-400,000 vol $0.54 each |
200,000 | |
Filed 2021-02-22 13:31 Tx date 2021-02-18 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
725,000 | |
Filed 2020-02-26 11:34 Tx date 2020-02-25 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
600,000 | |
Filed 2020-01-03 15:55 Tx date 2020-01-03 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-1,423,809 vol |
4,762 | |
Filed 2020-01-03 15:53 Tx date 2019-10-15 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$99,999
+1,428,571 vol $0.07 each |
||
Filed 2019-10-16 11:58 Tx date 2019-10-15 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$99,999
+1,428,571 vol $0.07 each |
||
Filed 2019-10-16 11:58 Tx date 2019-10-15 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$99,999
+1,428,571 vol $0.07 each |
2,857,142 | |
Filed 2019-09-11 11:42 Tx date 2019-09-09 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$99,999
+1,428,571 vol $0.07 each |
1,428,571 | |
Filed 2019-09-11 11:41 Tx date 2019-03-15 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-02-26 Tx date 2019-02-22 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$23,000
+100,000 vol $0.23 each |
475,000 | |
Filed 2017-12-20 Tx date 2017-12-19 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc. (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$104,000
+400,000 vol $0.26 each |
1,400,037 | |
Filed 2017-12-20 Tx date 2017-12-19 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-400,000 vol |
375,000 | |
Filed 2017-03-09 Tx date 2017-02-22 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-275,000 vol |
||
Filed 2017-03-09 Tx date 2017-02-22 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-125,000 vol |
775,000 | |
Filed 2017-03-02 Tx date 2017-02-22 |
$MBX
Microbix Biosystems Inc. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-275,000 vol |
625,000 |